Novartis AG (NVS)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$107.00

Buy

$110.00

arrow-up$1.13 (+1.04%)

Prices updated at 17 May 2025, 00:50 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.
S&P 500
arrow-up0.7%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20232024
46,660m51,722m
34,188m38,895m
9,769m14,544m
20.9428.12
14,850m11,941m
18,255m20,715m
Sales, General and administrative12,517m12,566m
Interest expenses855m1,006m
Provision for income taxes551m1,701m
Operating expenses24,419m24,351m
Income before taxes9,123m13,640m
Net income available to common shareholders14,850m11,941m
7.155.92
Net interest income-419m-686m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)7.15.87
Free cash flow per share6.21016.0965
Book value/share18.670921.9317
Debt equity ratio0.4292970.520683

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20232024
Current assets30,481m29,704m
Current liabilities26,390m28,692m
Total capital65,103m65,412m
Total debt26,348m31,258m
Total equity46,667m44,046m
Total non current liabilities--
Loans18,436m21,366m
Total assets99,945m102,246m
Total liabilities--
Cash and cash equivalents13,393m11,459m
Common stock2,044m1,975m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20232024
Cash at beginning of period7,517m13,393m
Cash dividends paid-7,255m-7,624m
11,705m13,805m
Investments (gains) losses5,596m-7,513m
13,393m11,459m
Net income--
14,458m17,619m
-2,753m-3,814m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.